Retinal angiomatous proliferation (RAP) is a unique variant of neovascular age-related
macular degeneration. Published studies have estimated that up to 15% of patients with …

Triamcinolone acetonide (TA) is one of the first pharmacologic compounds evaluated for the
treatment of choroidal neovascularization (CNV) secondary to age-related macular …

Purpose: To describe the occurrence of geographic atrophy in patients with retinal
angiomatous proliferation (RAP). Methods: Demographics, visual acuity, color fundus …

Type 3 macular neovascularization (MNV3), or retinal angiomatous proliferation (RAP), is a
distinct type of neovascular age-related macular degeneration (AMD), which is a leading …

Purpose: To evaluate the visual outcome of optical coherence tomography–based
ranibizumab monotherapy in Korean patients with retinal angiomatous proliferation and …

Purpose To assess the 1-year functional outcome and to evaluate the morphological
changes after intravitreal injections of ranibizumab in eyes affected with retinal angiomatous …

Introduction: Retinal angiomatous proliferation (RAP) is a subtype of neovascular age-
related macular degeneration (nAMD). Untreated, the lesions are thought to be aggressive …

Purpose To investigate the clinical significance of focal retinal pigment epithelium (RPE)
atrophy in the eyes with type 3 neovascularization. Methods This retrospective study …

Purpose: To investigate the efficacy and safety of initial photodynamic therapy (PDT) with a
ranibizumab loading dose of three monthly intravitreal injections and a subsequent PRN …

Purpose The aim of this study was clarify the efficacy of combination therapy of intravitreal
ranibizumab (IVR) injections and photodynamic therapy (PDT) in patients with symptomatic …